Article
Targeting mutant p53: Evaluation of novel anti-p53 R175H monoclonal antibodies as diagnostic tools
2024-09-26
Abstract excerpt
<title>Abstract</title> <p>About 50 % of all cancers carry a mutation in p53 that impairs its tumor suppressor function. The p53 missense mutation p53R175H (p53R172H in mice) is a hotspot mutation in cancer and the germline of Li-Fraumeni syndrome patients. Therefore, monoclonal antibodies selectively targeting clinically relevant mutations like p53R175H could prove immensely value. We aimed to evaluate the in vi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0bfd2f7d-bbe6-5343-b394-748c57c2123a
- DOI
- 10.21203/rs.3.rs-4907916/v1
